Calprotectin Testing Market Size, Share & Trend Analysis By Test Kits, By Sample, By Indication, By End-User, Regional Outlook, Competitive Tactics, and Segment Forecast to 2030

Calprotectin Testing Market Overview:

According to Reports and Insights analysis, the global calprotectin testing market is estimated to be US$ 198.3 Mn in 2022. Furthermore, the calprotectin testing market to register a CAGR of 6.4% which is expected to result in market forecast value for 2030 as US$ 326.3 Mn.

A fecal test called calprotectin is used to ascertain the level of intestinal inflammation. Increasing rates of irritable bowel syndrome and cancer around the world are driving up demand for calprotectin testing.

For illustration, the World Health Organization (WHO) reports that in 2020, 1.93 million new cases of colon and rectum cancer were reported worldwide.

The industry is also being stimulated by the focus on at-home testing, which has several advantages including the convenience of use and diagnosis. If the problem is getting worse and more frequent testing is necessary, these tests can be conveniently done between patient visits.

This aids in developing a suitable therapy plan that therapists may implement. As a result, several number of manufacturers are starting to release goods that include test kits for use at home.

This market study on the global calprotectin testing market aims to cover market dynamics such as market drivers, challenges/restraints, and opportunities for the market players. It will also cover market segmentation outlook, calprotectin testing market trend, regional outlook, calprotectin testing market size, and market share, as well as industry and product insights, SWOT analysis, Porter's five force analysis, PESTEL analysis, heat map analysis, market forecast, and the major players operating in the calprotectin testing market.

Download Free Sample Report

Scope of the Report:

Report Metric	Report Details
Market size available for the years	2022-2030
Base year	2021
Forecast Period	2022-2030
Segments Covered	By Test Kits, By Sample, By Indication, By End-User, and By Region
Regions Covered	North America, Latin America, Asia Pacific, Europe, Middle East, and Africa
Key Players	Abbexa, AccuBio Tech Co., Ltd., Actim Oy, American Laboratory Products Company, Ltd., Beckman Coulter Inc., Biohit Oyj, Boditech Med Inc., BUHLMANN Laboratories AG, Calpro AS, CerTest Biotec S.L., DiaSorin, DIAsource ImmunoAssays S.A, EagleBio, Elabscience Biotechnology Inc, Epitope Diagnostics, Inc.EUROIMMUN Medizinische Labordiagnostika AG, Hangzhou Biotest Biotech Co., Ltd, R-Biopharm AG., Screen Italia Srl., Thermo Fisher Scientific, Vitassay Healthcare, S.L.U., and among others

 

Calprotectin Testing Market Drivers:

Additionally, it is anticipated that the market will be driven during the projected period by intensifying healthcare expenses and quickly advancing medical infrastructure.

Additionally, the market is being advanced by the introduction of sophisticated and intelligent testing solutions. For instance, IBSibs-smart is a diagnostic kit that may be used to find anti-CdtB and anti-vinculin, two IBS biomarkers. It can identify IBS with mixed or diarrhea-dominant symptoms and gives information about IBS patients with diarrheal symptoms.

Additionally, the prevalence of IBD and irritable bowel syndrome (IBS) is climbing that leading to the increasing use of IBD remote monitoring, and there is an increase in demand for calprotectin testing. This in turn increases the need for active diagnostic testing for early diagnosis and effective treatment., This is due to several numbers of benefits, including a decrease in the workload of patients in the clinic and the medical staff. Individuals who frequently change their diets are more likely to develop IBS and IBD.

As these testing processes decrease visits and admissions to the centers and have close supervision over a longer period, sales are also anticipated to increase. Further, the patient's quality of life can be improved as the medical staff works around their schedule.

 

Calprotectin Testing Market Restraints:

There is a strong likelihood that results from calprotectin testing will be less reliable; this could further result in a false negative result and interfere with the patient's treatment plan. Repeated testing may be uncomfortable for the patient and prevent the market from accepting calprotectin testing.

Additionally, increased calprotectin levels may indicate that there is inflammation in the digestive system. However, the existence of IBD may not necessarily be indicated by high levels of calprotectin. As a result, it prevents the market from expanding throughout the forecasted period.

 

Calprotectin Testing Market Opportunities:

Fecal calprotectin (FC) is a biomarker for cancer as well as a sensitive and non-invasive diagnostic for inflammation of the gastrointestinal mucosa. Automated immunoassays have also become a viable testing option for conventional ELISA kits. This might help in better managing the workload in laboratories.

Furthermore, thanks to big data approaches, the generation, and availability of digital data are expanding, which improves analytical capacities. It will aid in the generation of fresh insights to enhance outcomes across numerous disciplines.

IBD will benefit from these applications for the creation of prediction models, precision medicine, epidemiological models, and drug discovery. Furthermore, the use of Big Data in calprotectin testing will open up new market expansion prospects.

Calprotectin Testing Market, by Test Kits:

Based on the Test Kits, the global calprotectin testing market is segmented into; Calprotectin ELISA Test Kits, and Calprotectin Rapid Testing Kits.

Calprotectin Testing Market, by Sample:

Based on the Sample, the global calprotectin testing market is segmented into; Stool, Blood Serum/Plasma, and Other Biological Samples.

Calprotectin Testing Market, by Indication:

Based on the Indication, the global calprotectin testing market is segmented into; Irritable Bowel Syndrome (IBS), Ulcerative Colitis, Crohn's Disease, and Colorectal Cancer.

Calprotectin Testing Market, by End-User:

Based on the End-User, the global calprotectin testing market is segmented into; Hospitals, Diagnostic Laboratories, and Specialty Clinics.

Calprotectin Testing Market, by Region:

Soaring Cancer Prevalence to Promote Calprotectin Testing Adoption

The U.S. is predicted to rule the North American calprotectin testing industry throughout the projection period and the tendency is probably going to persist.

As per the Centers for Disease Control and Prevention, colorectal cancer is the fourth most common cancer in the US, which will create the most lucrative market for calprotectin testing. Calprotectin testing will garner increasing interest as a result of investments and government assistance for numerous sectors of study.

Calprotectin testing demand is being driven by an increase in IBS cases in the United Kingdom.

Calprotectin testing kit sales will be boosted by the widespread use of the home testing kit

China, which has the prime share of the East Asian calprotectin testing market, is anticipated to rise rapidly during the forecast period due to growing emphasis on the home testing system.

Calprotectin testing demand will be fueled by the need for early disease defection

The South Asian calprotectin testing market is dominated by India, because of improvements in India's diagnostic infrastructure it is anticipated that India will grow at a strong CAGR over the forecast period.